-transparent.png){kind=logo}
The paper summarises updated knowledge concerning use of rHuEPO in patients with non-renal anemia. Taking into consideration hematological and clinical effects as well as improvement of general well-being obtained after EPO treatment, administration of this hormone is an essential extension of indication for this type of patients.
Related Publications
R Dyjas, and
A Wiecek, and
F Kokot
January 1991,
Acta medica portuguesa,
R Dyjas, and
A Wiecek, and
F Kokot
June 1995,
Annals of hematology,
R Dyjas, and
A Wiecek, and
F Kokot
January 2001,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
R Dyjas, and
A Wiecek, and
F Kokot
December 1997,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
R Dyjas, and
A Wiecek, and
F Kokot
December 1992,
Current opinion in nephrology and hypertension,
R Dyjas, and
A Wiecek, and
F Kokot
March 1989,
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
R Dyjas, and
A Wiecek, and
F Kokot
January 1989,
American journal of nephrology,
R Dyjas, and
A Wiecek, and
F Kokot
November 1988,
Polskie Archiwum Medycyny Wewnetrznej,
R Dyjas, and
A Wiecek, and
F Kokot
January 1992,
Przeglad lekarski,
R Dyjas, and
A Wiecek, and
F Kokot
December 1991,
Behring Institute Mitteilungen,
